Managing Neuropsychiatric Symptoms in Neurodegenerative Disease | The New York Academy of Sciences
Managing Neuropsychiatric Symptoms in Neurodegenerative Disease

Available via

WEBINAR

Psychiatric Symptoms in Alzheimer’s Disease and Dementia

Thursday, June 14, 2018

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

The Brain and Behavior Discussion Group

The New York Academy of Sciences

 

Neuropsychiatric symptoms such as agitation, aggression and psychosis are frequently found in patients with neurodegenerative disorders. These symptoms increase the already significant burden of neurodegenerative diseases and complicate diagnosis and disease management, yet effective diagnostics and treatments are lacking.

Towards the goal of reducing this burden, this symposium will review state-of-the-art methods in the diagnosis and behavioral and pharmaceutical management of neuropsychiatric symptoms across a spectrum of neurodegenerative diseases. Speakers will address the challenges of defining neuropsychiatric symptoms in the context of neurodegenerative diseases, present findings regarding emerging diagnostic biomarkers and novel therapies, and discuss current estimates of associated societal and economic costs. A closing panel discussion will identify strategies to reduce these costs for patients, caregivers, and society.

Registration

Member
$60
Nonmember Academia, Faculty, etc.
$105
Nonmember Corporate, Other
$160
Nonmember Not for Profit
$105
Nonmember Student, Undergrad, Grad, Fellow
$70
Member Student, Post-Doc, Fellow
$25
Member
$30
Nonmember Academia, Faculty, etc.
$65
Nonmember Corporate, Other
$85
Nonmember Not for Profit
$65
Nonmember Student, Undergrad, Grad, Fellow
$45
Member Student, Post-Doc, Fellow
$15
Deadline:
0
days
left

Keynote Speaker

Managing Neuropsychiatric Symptoms in Neurodegenerative Disease
Jeff Cummings, MD,
Cleveland Clinic Lou Ruvo Center for Brain Health

Speakers

Managing Neuropsychiatric Symptoms in Neurodegenerative Disease
Andrew Satlin, MD,
Intra-Cellular Therapies
Managing Neuropsychiatric Symptoms in Neurodegenerative Disease
George T. Grossberg, MD,
Saint Louis University School of Medicine
Managing Neuropsychiatric Symptoms in Neurodegenerative Disease
Ruth A. Duffy, PhD,
Otsuka
Managing Neuropsychiatric Symptoms in Neurodegenerative Disease
Krista Lanctôt, PhD,
University of Toronto and Sunnybrook Health Science Centre
Managing Neuropsychiatric Symptoms in Neurodegenerative Disease
Scott Russo, PhD,
Icahn School of Medicine at Mount Sinai
Managing Neuropsychiatric Symptoms in Neurodegenerative Disease
Howard Fillit, MD,
Alzheimer’s Drug Discovery Foundation
Managing Neuropsychiatric Symptoms in Neurodegenerative Disease
Mary Sano, PhD,
Icahn School of Medicine at Mount Sinai and James J. Peters VA Medical Center
Managing Neuropsychiatric Symptoms in Neurodegenerative Disease
Murray Raskind, MD,
University of Washington and VA Puget Sound Health Care System
Managing Neuropsychiatric Symptoms in Neurodegenerative Disease
James Leverenz, MD,
Cleveland Lou Ruvo Center for Brain Health at Cleveland Clinic

Event Sponsors


Thursday

June 14, 2018

8:30 AM

Breakfast and Registration

9:00 AM

Introduction and Welcome Remarks

Speakers

Sonya Dougal, PhD
The New York Academy of Sciences
Howard Fillit, MD
Alzheimer's Drug Discovery Foundation

Session 1: Neuropsychiatric Symptoms in Neurodegenerative Diseases

Session Chairperson
Howard Fillit, MD, Alzheimer's Drug Discovery Foundation
9:15 AM

Keynote Address: Defining and Diagnosing Neuropsychiatric Symptoms in Neurodegenerative Disorders

Speaker

Jeff Cummings, MD, ScD
Cleveland Clinic Lou Ruvo Center for Brain Health
10:00 AM

Measuring Neuropsychiatric Symptoms for Diagnosis and Outcomes

Speaker

Mary Sano, PhD
Icahn School of Medicine at Mount Sinai; Bronx Veterans Affairs Hospital
10:30 AM

Networking Coffee Break

Session 2: The Neurobiology of Neuropsychiatric Symptoms

Session Chairperson
Thomas Franke, MD, PhD, Icahn School of Medicine at Mount Sinai
11:00 AM

The Neural Circuitry of Aggression

Speaker

Scott Russo, PhD
Icahn School of Medicine at Mount Sinai
11:30 AM

Brain Noradrenergic Systems and Agitation in Alzheimer’s Disease

Speaker

Murray Raskind, MD
University of Washington; Veterans Affairs Puget Sound Health Care System
12:00 PM

Pathobiology of Non-Motor Complications in Parkinson’s Disease

Speaker

James Leverenz, MD
Cleveland Lou Ruvo Center for Brain Health
12:30 PM

Networking Lunch and Poster Session

Session 3: Defining the Costs of Neuropsychiatric Symptoms in Neurodegenerative Diseases

1:30 PM

The Costs of Neuropsychiatric Symptoms in Neurodegenerative Diseases: Economic, Social, and Societal Implications

Speaker

Howard Fillit, MD
Alzheimer's Drug Discovery Foundation

Session 4: State of the Art Treatments: Diagnosis and Management

Session Chairperson
Sonya Dougal, PhD, The New York Academy of Sciences
2:00 PM

Neuroanatomic and Neurochemical Substrates of Behavioral Symptoms in Alzheimer's Disease: Implications for Treatment

Speaker

George T. Grossberg, MD
St. Louis University School of Medicine
2:30 PM

Biomarkers and Behaviors: Using Biomarkers to Inform Treatment of Neuropsychiatric Symptoms in Neurodegenerative Diseases

Speaker

Krista Lanctôt, PhD
University of Toronto
3:00 PM

Networking Coffee Break

3:30 PM

Unique Mechanism of Action of a Novel Antipsychotic for Psychiatric Symptoms in Neurological Disorders

Speaker

Andrew Satlin, MD
Intra-Cellular Therapies
4:00 PM

Panel Discussion: Reducing the Burden of Neuropsychiatric Symptoms in Neurodegenerative Diseases for Patients, Caregivers, and Society

Speaker

Ruth Duffy, PhD
Otsuka Pharmaceutical Development and Commercialization
4:45 PM

Closing Remarks

Speaker

Sonya Dougal, PhD
The New York Academy of Sciences
5:00 PM

Networking Reception

6:00 PM

Adjourn

To view full attendee list, you must first register for the event, then log in to the Academy website. This list is provided for the personal, noncommercial and informational use only of event attendees, in a manner that is consistent with the New York Academy of Sciences’ mission, goals and activities.
  • Alzheimer's Drug Discovery Foundation

  • Anavex Life Sciences Corp.

  • C Wilmot Consulting, LLC

  • Charles River Laboratories International, Inc.

  • Cleveland Clinic Lou Ruvo Center for Brain Health

  • Cleveland Lou Ruvo Center for Brain Health at Cleveland Clinic

  • Cold Spring Harbor Laboratory

  • Columbia University

  • Columbia University Irving Medical Center

  • Cornell Medical Center

  • Drew University

  • Eli Lilly and Company

  • Forest Research Institute

  • H. Lundbeck A/S

  • Icahn School of Medicine at Mount Sinai and Bronx Veterans Administration Hospital

  • In Silico Biosciences

  • INmune Bio

  • Intra-Cellular Therapies, Inc

  • JM Neuroscience, LLC

  • Lundbeck

  • Mount Sinai Medical Center

  • NYU School of Medicine

  • Otsuka

  • Otsuka America Pharmaceutical, Inc.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.

  • Pfizer Inc.

  • Piramal Group

  • Privat Practice

  • Rutgers University - New Brunswick

  • Saint Louis University School of Medicine

  • SQI Diagnostics

  • St. Johns University, NY

  • Sunovion

  • Tabasco Health Care

  • The CUNY Graduate Center

  • The Icahn School of Medicine at Mount Sinai

  • The Lessac Group

  • University of Toronto and Sunnybrook Health Science Centre

  • University of Washington

  • University of Washington and VA Puget Sound Health Care System

  • Weill Cornell Graduate School of Medical Sciences

This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.